Perspectives - Page 32

The UK Joining Project Orbis Post-Brexit May Mean Compressed Timelines and Less Data for Health Technology Assessment Submissions

On Monday last week, UK Health Secretary Matt Hancock announced to the House of Commons that the UK will be part of Project Orbis, joining Canada, the United States, Australia, Switzerland and Singapore.

View Oct 12, 2020

Today is Rare Cancer Day

View Sep 30, 2020

Medical Affairs Unscripted | Data Generation: The Intersection Between Medical Affairs and Clinical Development with Dr Adam Schayowitz

Podcast Sep 29, 2020

Sweaty Kids: How Does It Feel To Have Hyperhidrosis?

Sep 21, 2020

Searching for the New Normal: Are Improvements to Clinical Management Making COVID-19 a Serious and Unpleasant – but Survivable – Condition?

View Sep 9, 2020

NICE Technical Engagement Process: Navigating the Latest Changes

Over the course of our multiple recent conversations with the UK’s National Institute for Health and Care Excellence (NICE) as part of decision problem and checkpoint meetings, we are hearing from them that they are currently trialing revisions to their technical engagement process in an effort to address some of the challenges that have begun to emerge since its initial release.

Whitepaper Aug 21, 2020

Medical Affairs Unscripted | Building an Integrated Engagement Roadmap with Randi Goeckeler

Podcast Aug 18, 2020

Social Media and the Impact on Healthcare

View Aug 17, 2020

Vindication for Microbiome-Led Biotech: Will it Drive Renewed Interest in the Field?

View Aug 11, 2020

Woozles and Data Transparency

View Aug 6, 2020

Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape – Part I

Perhaps more so than any other modality to date, cancer cell therapies have captured the imaginations and wherewithal of industry, investor, and oncologist communities alike...

View Aug 6, 2020

Living With the Two Big C’s: Cancer Patients and the COVID-19 Pandemic

View Aug 4, 2020

Using Gestalt Psychotherapeutic Techniques in Market Research

Aug 3, 2020

Turning Anticancer Therapy Inside-Out (Part I): From Exogenous to Endogenous—Moving Treatment In Situ

Jul 30, 2020

Competitor Planning and Response – Embracing Fresh Opportunities

Jul 22, 2020

Medical Affairs Unscripted | The Business Objective of Medical Affairs with Holly Schachner, MD

During this episode of Medical Affairs Unscripted, Dr Crowley-Nowick has a conversation with Holly Schachner, MD, former CMO of Specialty Medicine at Allergan to examine the business objective of medical affairs (MA) organizations and how MA can move closer to being identified as a strategic pillar within the life sciences industry alongside the research & development and commercial organizations.

Podcast Jul 20, 2020